Cheng serves as a consultant/advisory board member for Abbott Diabetes Care, AstraZeneca, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly and Company, HLS Therapeutics, Insulet, Janssen, Novo Nordisk, and Sanofi
Every treatment plan starts with a personalized consultation to determine the right combination of therapies for your unique needs
A weakened glycocalyx can further increase the risk of gut dysbiosis (see Histamine test)
A study by Whitley Law Firm used prescription data to determine GLP-1 usage rates across the U.S
Is it the Semaglutide chemically messing with my brain
In the SURMOUNT-1 trial, the most significant results built gradually over a full 72 weeks of treatment, so tirzepatide works best as a sustained, longer-term part of your weight loss program rather than a quick fix